Medications called incretin-based therapies, such as GLP-1 receptor agonists, lower systolic blood pressure by about 3.4 mmHg and diastolic blood pressure by about 0.9 mmHg in adults who have...

Medications that activate multiple related hormone receptors lower blood pressure more than those activating only one receptor in adults with overweight or obesity, with measurable differences in systolic and diastolic readings.

In adults with overweight or obesity who are taking incretin-based therapies, those who lose more weight tend to have larger decreases in both their systolic and diastolic blood pressure.